Effects of atrial natriuretic factor in rats with experimental high-output heart failure. The effects of atrial natriuretic factor (AN F) were evaluated in rats with chronic aorto-caval (A-V) fistula. In this experimental model of high-output heart failure, the animals display elevated atrial pressure and systemic vasodilation, but avidly retain sodium. Experiments were performed on Munich-Wistar rats, 8 to 14 days after placement of an infrarenal surgical anastomosis (side-to-side, 0.9 0.2 mm) and on sham operated controls. Infusion of synthetic intravenously (5 jg/kg prime; 0.17 jgIkg mm) resulted in increases in urine flow (V) and fractional sodium excretion (FENa) and decreases in blood pressure (BP) that were significantly attenuated in rats with A-V fistula compared to controls. To control for the lower baseline BP that was present in rats with A-V fistula, a second series of studies was performed in which renal perfusion pressure was reduced in normal rats to 110 mm Hg with a servocontrolled pneumatic cuff. ANF infusion to this group led to significant increases in glomerular filtration rate (GFR), V and FENa that were greater than those seen in rats with A-V fistula (FENa = 2.7 0.3% vs. 0.48 0.12%, P <0.05). Thus, the moderately reduced BP in rats with A-V fistula did not account for the blunted response to ANF. To investigate whether the renal sensitivity to ANF is altered in this model, an additional series of experiments were performed in which ANF was infused over a range of doses (0.08 to 2.5 jg/kg'min) to both groups of rats. The changes in BP, GFR, V and FENa following the incremental doses of ANF were significantly attenuated in rats with A-V fistula. Indeed, the maximum natriuresis in rats with A-V fistula was significantly lower in rats with A-V fistula compared to controls (FENa = 2.1 0.7% vs. 5.0 0.5%, P < 0.05).
Effects of atrial natriuretic factor in rats with experimental high-output heart failure. The effects of atrial natriuretic factor (AN F) were evaluated in rats with chronic aorto-caval (A-V) fistula. In this experimental model of high-output heart failure, the animals display elevated atrial pressure and systemic vasodilation, but avidly retain sodium. Experiments were performed on Munich-Wistar rats, 8 to 14 days after placement of an infrarenal surgical anastomosis (side-to-side, 0.9 0.2 mm) and on sham operated controls. Infusion of synthetic ANF intravenously (5 jg/kg prime; 0.17 jgIkg mm) resulted in increases in urine flow (V) and fractional sodium excretion (FENa) and decreases in blood pressure (BP) that were significantly attenuated in rats with A-V fistula compared to controls. To control for the lower baseline BP that was present in rats with A-V fistula, a second series of studies was performed in which renal perfusion pressure was reduced in normal rats to 110 mm Hg with a servocontrolled pneumatic cuff. ANF infusion to this group led to significant increases in glomerular filtration rate (GFR), V and FENa that were greater than those seen in rats with A-V fistula (FENa = 2.7 0.3% vs. 0.48 0.12%, P <0.05). Thus, the moderately reduced BP in rats with A-V fistula did not account for the blunted response to ANF. To investigate whether the renal sensitivity to ANF is altered in this model, an additional series of experiments were performed in which ANF was infused over a range of doses (0.08 to 2.5 jg/kg'min) to both groups of rats. The changes in BP, GFR, V and FENa following the incremental doses of ANF were significantly attenuated in rats with A-V fistula. Indeed, the maximum natriuresis in rats with A-V fistula was significantly lower in rats with A-V fistula compared to controls (FENa = 2.1 0.7% vs. 5.0 0.5%, P < 0.05).
These data indicate that rats with A-V fistula have a diminished sensitivity to ANF infusion. The blunted natriuretic response to ANF may contribute to the renal retention of sodium in this experimental model of heart failure.
Recent investigations have established that mammalian atria synthesize and release a vasoactive and natriuretic peptide termed, atrial natriuretic factor (ANF) L!-4]. This newly identified hormone is released during expansion of the extracellular volume [5] [6] [7] [8] , presumably as a consequence of an increase in atrial pressure and distension of the atria [9, 10] . Exogenous infusion of ANF results in an increase in glomerular filtration rate, sodium and water excretion and inhibition of the reninangiotensin-aldosterone system, despite a reduction in arterial pressure 11, 12] .
Studies in animals with experimental heart failure have reported that the renal natriuretic response to exogenous administration of ANF was markedly attenuated [23, 241 . The reduced excretion of sodium occurred in the presence of an intact effect of ANF to increase the glomerular filtration rate and to decrease arterial pressure. However, while these previous studies have provided insight into the renal and vasoactive responses to ANF in heart failure, the experimental model that was used may not have appropriately simulated the clinical syndrome of congestive heart failure. The earlier investigations were performed in low output states produced by thoracic caval constriction in which cardiac filling pressures are decreased rather than increased. Thus, circulating levels of ANF were probably low, in contrast to the elevated levels characteristic of the clinical syndrome.
The present study was therefore performed to evaluate the effects of ANF in rats with chronic aorto-caval fistula. In this experimental model of heart failure, central venous pressures and circulating levels of ANF are elevated 25], yet the animals avidly retain sodium leading to the formation of ascites and peripheral edema [13, [26] [27] [28] .
Methods
Studies were performed on Munich-Wistar rats (Haifa strain) weighing 200 to 250 g. The animals were anesthetized with sodium pentobarbital (35 mg/kg), and a surgical anastomosis was placed between the abdominal aorta and inferior vena cava distal to the origin of the renal arteries (side-to-side, 0.9 0.2 mm) according to the method described by Stumpe et al [29j.
An additional matched group of animals underwent sham operation. In this group, the aorta and vena cava were dissected from the surrounding tissue and clamped for 5 to 10 minutes without formation of a fistula. The animals were then placed in individual metabolic cages and were maintained on standard rat chow diet and tap water. To document some of the cardio-renal Effects of atrial natriuretic factor in rats with experimental high-output heart failure. The effects of atrial natriuretic factor (ANF) were evaluated in rats with chronic aorto-caval (A-V) fistula. In this experimental model of high-output heart failure, the animals display elevated atrial pressure and systemic vasodilation, but avidly retain sodium. Experiments were performed on Munich-Wistar rats, 8 to 14 days after placement of an infrarenal surgical anastomosis (side-to-side, 0.9 0.2 mm) and on sham operated controls, Infusion of synthetic ANF intravenously (5 sg/kg prime; 0.17 sgIkg mm) resulted in increases in urine flow (V) and fractional sodium excretion (FENa) and decreases in blood pressure (BP) that were significantly attenuated in rats with A-V fistula compared to controls. To control for the lower baseline BP that was present in rats with A-V fistula, a second series of studies was performed in which renal perfusion pressure was reduced in normal rats to 110 mm Hg with a servocontrolled pneumatic cuff. ANF infusion to this group led to significant increases in glomerular filtration rate (GFR), V and FENa that were greater than those seen in rats with A-V fistula (FENa = 2.7 0.3% vs. 0.48 0.12%, P < 0.05). Thus, the moderately reduced BP in rats with A-V fistula did not account for the blunted response to ANF. To investigate whether the renal sensitivity to ANF is altered in this model, an additional series of experiments were performed in which ANF was infused over a range of doses (0.08 to 2.5 sg/kgmin) to both groups of rats. The changes in BP, GFR, V and FENa following the incremental doses of ANF were significantly attenuated in rats with A-V fistula. Indeed, the maximum natriuresis in rats with A-V fistula was significantly lower in rats with A-V fistula compared to controls (FENa = 2.1 0.7% vs. 5.0 0.5%, P < 0.05).
Recent investigations have established that mammalian atria synthesize and release a vasoactive and natriuretic peptide termed, atrial natriuretic factor (ANF) [1] [2] [3] [4] . This newly identified hormone is released during expansion of the extracellular volume [5] [6] [7] [8] , presumably as a consequence of an increase in atrial pressure and distension of the atria [9, 10] . Exogenous infusion of ANF results in an increase in glomerular filtration rate, sodium and water excretion and inhibition of the reninangiotensin-aldosterone system, despite a reduction in arterial pressure [11, 12] .
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Congestive heart failure is a syndrome characterized by increased atrial pressures, decreased arterial pressure, avid sodium retention with edema formation and activation of the renin-angiotensin-aldosterone system [13, 14] . Although initial reports suggested that cardiac failure may be associated with a deficiency of ANF [15, 16] , more recent studies have clearly established that circulating concentrations of the atrial peptide are elevated in heart failure [17] [18] [19] [20] [21] [22] .
Studies in animals with experimental heart failure have reported that the renal natriuretic response to exogenous administration of ANF was markedly attenuated [23, 24] . The reduced excretion of sodium occurred in the presence of an intact effect of ANF to increase the glomerular filtration rate and to decrease arterial pressure. However, while these previous studies have provided insight into the renal and vasoactive responses to ANF in heart failure, the experimental model that was used may not have appropriately simulated the clinical syndrome of congestive heart failure. The earlier investigations were performed in low output states produced by thoracic caval constriction in which cardiac filling pressures are decreased rather than increased. Thus, circulating levels of ANF were probably low, in contrast to the elevated levels characteristic of the clinical syndrome.
The present study was therefore performed to evaluate the effects of ANF in rats with chronic aorto-caval fistula. In this experimental model of heart failure, central venous pressures and circulating levels of ANF are elevated [25] , yet the animals avidly retain sodium leading to the formation of ascites and peripheral edema [13, [26] [27] [28] .
Methods
Studies were performed on Munich-Wistar rats (Haifa strain) weighing 200 to 250 g. The animals were anesthetized with sodium pentobarbital (35 mg/kg), and a surgical anastomosis was placed between the abdominal aorta and inferior vena cava distal to the origin of the renal arteries (side-to-side, 0.9 0.2 mm) according to the method described by Stumpe et al [29] . An additional matched group of animals underwent sham operation. In this group, the aorta and vena cava were dissected from the surrounding tissue and clamped for 5 to 10 minutes without formation of a fistula. The animals were then placed in individual metabolic cages and were maintained on standard rat chow diet and tap water. To document some of the cardio-renal and endocrine changes that were induced by placement of the A-V fistula, heart weight and plasma renin activity were determined in several animals, seven days following the operation.
Eight to fourteen days following the operation the rats were anesthetized with an intraperitoneal injection of mactin (100 mg/kg; BYK Guldens, Konstanz, FRG) and prepared for clearance experiments. The animals were placed on a temperatureregulated table and body temperature was monitored with a rectal probe. A tracheostomy was performed to clear the airway. Polyethylene catheters were inserted in the jugular vein for infusions, in the carotid artery for blood pressure measurement and periodic blood sampling, and in the bladder for urine collections.
A solution containing 2% inulin in normal saline was infused intravenously at a rate equal to 1.5% of the body weight per hour. Following an equilibration period of 60 to 80 minutes, one of the three protocols described below was performed.
Series I: Renal and systemic response to ANF infusion In this series the effects of a single dose infusion of atrial natriuretic factor was evaluated in seven rats with aorto-caval (A-V) fistula and in six sham-operated control rats. Two baseline clearance periods of 20 minutes each were obtained. Urine was collected into tared vials under mineral oil, and blood samples were withdrawn into heparinized syringes at the midpoint of each clearance period. Following these control collections, synthetic atrial natriuretic factor (26 amino acid, 3-28, Peninsula Labs) was administered intravenously as a bolus (5 sag/kg) and followed by a sustained infusion (0.17 pg/kg . mm).
Urinary losses of sodium and volume were replaced with isotonic saline. Thirty minutes after the initiation of the ANF infusion, two clearance periods were obtained. At this point the infusion of ANF was stopped and after thirty minutes two additional urine collections were obtained (recovery phase). In separate groups of rats with A-V fistula (N = 18) and sham operated controls (N = 8) measurements were made of baseline circulating ANF levels. These groups were not infused with synthetic ANF. Series 2: Dose response protocol This series of studies was performed to evaluate the response of rats with A-V fistula (N = 6) and sham operated controls (N = 6) to increasing doses of ANF. Following two, 30-minute control clearance periods, ANF was administered in incremental doses from 5 to 150 pg/kg as a bolus and continued with a sustained infusion of the same dose for sixty minutes. Urine collections were started after the peptide had been infused for thirty minutes. In preliminary studies, the maximal natriuretic and hemodynamic effects of ANF in normal rats were observed with doses between 15 and 50 j.gJkg. Therefore, the very high dose of 150 pg/kg was not given to the sham-operated control group in this study. Series 3: Response to ANF in normal rats during control of renal peifusion pressure This series of experiments were performed in normal rats to assess the effects of ANF under conditions where renal perfusion pressure was lowered to the levels seen in rats with A-V fistula. The protocol was identical to series I with the exception that, after an initial control clearance period of 30 minutes, renal perfusion pressure was reduced to 110 mm Hg with an inflatable silastic cuff placed on the aorta above the renal arteries. The cuff was connected to an electronic servocontrolling system that precisely maintained renal perfusion pressure at that level for the duration of the experiment.
Inulin concentrations in plasma and urine were measured by the anthrone method. Sodium and potassium concentrations were measured by flame photometry. Plasma renin activity was measured at pH 6.0 using a commercially available kit (New England Nuclear, Boston, Massachusetts, USA). Concentrations of immunoreactive ANF were measured in extracted plasma by a sensitive radioimmunoassay previously described t171. Briefly, samples were extracted on Sep-Pak, C-18 cartridges and dried in a vacuum. The samples were reconstituted for radioimmunoassay, the recovery being greater than 80%. The antibody and labelled peptide were purchased from Peninsula Labs (CA). The intraassay and interassay variabilities were 6% and 9%, respectively. The sensitivity of the assay is 3 pg/mI.
Statistical analysis
The data are presented as means SEM. Statistical comparisons between groups were made with analysis of variance for repeated measures, and Student t-test for unpaired data. Comparisons within groups were made with paired t-test. A P valve of 0.05 or less was considered to represent a significant difference.
Results
The placement of a chronic A-V fistula in rats resulted in several expected effects, such as atrial hypertrophy and tachypnea. The liver was enlarged and, in most rats, was accompanied with ascites. Quantitative changes in several cardio-renal and endocrine parameters are given in Table 1 .
Most notably, heart weight, central venous pressure and plasma renin activity were elevated in rats with A-V fistula compared to controls. This was associated with diminished urinary excretion of sodium. These data indicate that the experimental model of A-V fistula in rats resembles the clinical syndrome of congestive heart failure.
Hoffman ci a!: Effects of ANF in heart failure 657 and endocrine changes that were induced by placement of the A-V fistula, heart weight and plasma renin activity were determined in several animals, seven days following the operation.
Series I: Renal and systemic response to ANF infusion In this series the effects of a single dose infusion of atrial natriuretic factor was evaluated in seven rats with aorto-caval (A-V) fistula and in six sham-operated control rats. Two baseline clearance periods of 20 minutes each were obtained. Urine was collected into tared vials under mineral oil, and blood samples were withdrawn into heparinized syringes at the midpoint of each clearance period. Following these control collections, synthetic atrial natriuretic factor (26 amino acid, 3-28, Peninsula Labs) was administered intravenously as a bolus (5 zg/kg) and followed by a sustained infusion (0.17 pg/kg . mm).
Urinary losses of sodium and volume were replaced with isotonic saline. Thirty minutes after the initiation of the ANF infusion, two clearance periods were obtained. At this point the infusion of ANF was stopped and after thirty minutes two additional urine collections were obtained (recovery phase). In separate groups of rats with A-V fistula (N = 18) and sham operated controls (N = 8) measurements were made of baseline circulating ANF levels. These groups were not infused with synthetic ANF. Series 2: Dose response protocol This series of studies was performed to evaluate the response of rats with A-V fistula (N = 6) and sham operated controls (N = 6) to increasing doses of ANF. Following two, 30-minute control clearance periods, ANF was administered in incremental doses from S to 150 pg/kg as a bolus and continued with a sustained infusion of the same dose for sixty minutes. Urine collections were started after the peptide had been infused for thirty minutes. In preliminary studies, the maximal natriuretic and hemodynamic effects of ANF in normal rats were observed with doses between 15 and 50 sg/kg. Therefore, the very high dose of 150 pg/kg was not given to the sham-operated control group in this study.
Series 3: Response to ANF in normal rats during control of renal peifus ion pressure This series of experiments were performed in normal rats to assess the effects of ANF under conditions where renal perfusion pressure was lowered to the levels seen in rats with A-V fistula. The protocol was identical to series 1 with the exception that, after an initial control clearance period of 30 minutes, renal perfusion pressure was reduced to 110 mm Hg with an inflatable silastic cuff placed on the aorta above the renal arteries. The cuff was connected to an electronic servocontrolling system that precisely maintained renal perfusion pressure at that level for the duration of the experiment.
Inulin concentrations in plasma and urine were measured by the anthrone method. Sodium and potassium concentrations were measured by flame photometry. Plasma renin activity was measured at pH 6.0 using a commercially available kit (New England Nuclear, Boston, Massachusetts, USA). Concentrations of immunoreactive ANF were measured in extracted plasma by a sensitive radioimmunoassay previously described tl7I. Briefly, samples were extracted on Sep-Pak, C-l8 cartridges and dried in a vacuum. The samples were reconstituted for radioimmunoassay, the recovery being greater than 80%. The antibody and labelled peptide were purchased from Peninsula Labs (CA). The intraassay and interassay variabilities were 6% and 9%, respectively. The sensitivity of the assay is 3 pg/mI.
Statistical analysis
Results
Most notably, heart weight, central venous pressure and plasma renin activity were elevated in rats with A-V fistula compared to controls. This was associated with diminished urinary excretion of sodium. These data indicate that the experimental model of A-V fistula in rats resembles the clinical syndrome of congestive heart failure. The results of this series are Summarized in Table 2 . Administration of ANF to sham operated animals significantly decreased mean arterial blood pressure, and significantly increased the glomerular filtration rate. Urine flow and absolute and fractional excretion of sodium and potassium rose significantly. These changes returned towards control levels upon cessation of ANF infusion.
In rats with A-V fistula, baseline systemic blood pressure was 20% lower than in sham controls, but the glomerular filtration rate did not differ significantly and was maintained. However, as indicated earlier in Table 1 , central venous pressure in rats with A-V fistula was significantly greater than in control rats. This was associated with significantly higher circulating levels of immunoreactive ANF in rats with A-V fistula compared to sham-operated control rats (Fig. 1) . As expected, the initial urine flow and excretion of sodium and potassium were significantly lower in the experimental group compared to the control group.
Infusion of ANF lead to significant decreases in mean arterial blood pressure and to significant increases in urine flow and absolute excretion of sodium and potassium. However, the changes were markedly attenuated in rats with A-V fistula compared to the sham-operated control group. Indeed, the fractional excretion of sodium during infusion of ANF did not exceed 1%, Interestingly, there were no significant changes in the glomerular filtration rate during ANF infusion in the experimental group. Thus, the natriuresis, diuresis, and vasodilation accompanying the administration of a single dose of ANF were significantly blunted in rats with A-V fistula. To examine whether the attenuated response to ANF infusion reflected a change in sensitivity to ANF, a second series of studies were performed in which the response to increasing doses of ANF was evaluated in control rats and in rats with A-V fistula, 
Dose response protocol
Data regarding the response of sham-operated rats to increasing doses of ANF are given in Table 3 . Administration of ANE lead to dose dependent decreases in mean arterial blood pressure and to increases in the glomerular filtration rate. Urine flow and absolute, as well as fractional, excretion of sodium rose progressively. With the exception of the effect of ANF on systemic blood pressure, a maximal response in these parameters was obtained in most animals at a dose ranging between 5 and 15 jig/kg hr. Submaximal responses were seen at higher doses of ANF, most likely as a consequence of the further decline in blood pressure.
The results in rats with A-V fistula appear in Table 4 .
Increasing doses of ANF resulted in progressive decreases in mean arterial blood pressure and steady increases in urine flow and sodium excretion. The slight increments in the glomerular filtration rate did not attain statistical significance. In an attempt to reach a maximal response, a dose of 150 gIkg hr was given Values and means SE for six animals. Abbreviations are given in Table 2 .
a Statistically different (P 0.05) compared to first period where no ANF was administered b P 0.05 compared to previous dose of ANF 
Renal and systemic response to ANF infusion
The results of this series are summarized in Table 2 . Administration of ANF to sham operated animals significantly decreased mean arterial blood pressure, and significantly increased the glomerular filtration rate. Urine flow and absolute and fractional excretion of sodium and potassium rose significantly. These changes returned towards control levels upon cessation of ANF infusion.
In rats with A-V fistula, baseline systemic blood pressure was 20% lower than in sham controls, but the glomerular filtration rate did not differ significantly and was maintained. However, as indicated earlier in Table 1 , central venous pressure in rats with A-V fistula was significantly greater than in control rats. This was associated with significantly higher circulating levels of immunoreactive ANF in rats with A-V fistula compared to sham-operated control rats (Fig. I) . As expected, the initial urine flow and excretion of sodium and potassium were significantly lower in the experimental group compared to the control group.
Infusion of ANF lead to significant decreases in mean arterial blood pressure and to significant increases in urine flow and absolute excretion of sodium and potassium. However, the changes were markedly attenuated in rats with A-V fistula compared to the sham-operated control group. Indeed, the fractional excretion of sodium during infusion of ANF did not exceed 1%, Interestingly, there were no significant changes in the glomerular filtration rate during ANF infusion in the experimental group. Thus, the natriuresis, diuresis, and vasodilation accompanying the administration of a single dose of ANF were significantly blunted in rats with A-V fistula. To examine whether the attenuated response to ANF infusion reflected a change in sensitivity to ANF, a second series of studies were performed in which the response to increasing doses of ANF was evaluated in control rats and in rats with A-V fistula. 
Dose response protocol
Data regarding the response of sham-operated rats to increasing doses of ANF are given in Table 3 . Administration of ANF lead to dose dependent decreases in mean arterial blood pressure and to increases in the glomerular filtration rate. Urine flow and absolute, as well as fractional, excretion of sodium rose progressively. With the exception of the effect of ANF on systemic blood pressure, a maximal response in these parameters was obtained in most animals at a dose ranging between 5 and 15 jig/kg hr. Submaximal responses were seen at higher doses of ANF, most likely as a consequence of the further decline in blood pressure.
Increasing doses of ANF resulted in progressive decreases in mean arterial blood pressure and steady increases in urine flow and sodium excretion. The slight increments in the glomerular filtration rate did not attain statistical significance. In an attempt to reach a maximal response, a dose of 150 1kg/kg hr was given Table 2 .
a Statistically different (P 0.05) compared to first period where no ANF was administered b P 0.05 compared to previous dose of ANF Values are means SE for six animals. Abbreviations are given in Table 2. P 0.05 compared to first period where no ANF was administered b P < 0.05 compared to previous dose of ANF to this group. However, during infusion of this dose there were no further changes in blood pressure. Indeed, with the exception of the fractional excretion of sodium, other parameters actually declined. The responses of both sham operated rats and rats with A-V fistula to increasing doses of ANF are compared in Figures 2  and 3 . The glomerular filtration rate (Fig. 2) and, the fractional excretion of sodium (Fig. 3) are plotted for each dose of ANF. In this series, the baseline values for the glomerular filtration rate and fractional excretion of sodium were significantly lower in rats with A-V fistula compared to sham operated controls. Furthermore, the increases in both parameters following ANF administration were significantfy attenuated in rats with A-V fistula. Indeed, there was no significant increase in the glomerular filtration rate and the fractional excretion of sodium, even at the highest dose of ANF, was only 291c-a significantly lower value than in control rats. This apparent "shift to the right" of the dose response curve suggests either that rats with A-V fistula have diminished sensitivity to ANF or that perhaps the lower baseline systemic blood pressure altered the hemodynamic and, consequently, the natriuretic response to ANF. To further examine this issue, the next series was performed wherein renal perfusion pressure was lowered in normal rats to the level seen in rats with A-V fistula.
Response to ANF in normal rats during control ofrenal perfusion pressure The results of this series of experiments are shown in Figure  4 . Renal perfusion pressure in normal rats was lowered from 134 mm Hg to 110 mm Hg, and maintained at that level throughout the experiment. Administration of ANF lead to significant increases in glomerular filtration rate (from 1.01 0.11 to 1.38 0.29 mI/mm, P < 0.05), urine flow (from 9 2 to 33 3 p1/mm, P < 0.05) and fractional excretion of sodium (from 0.5 0.2 to 2.7 0.3%, P < 0.05). The results demonstrate that a significant natriuresis and diuresis can occur in an animal with moderately-reduced renal perfusion pressure. More importantly, these data indicate that the blunted natriuresis and diuresis that occurred in response to ANF in rats with A-V fistula is not a direct result of the lower renal perfusion pressure present in those animals.
Discussion
The present study demonstrates that rats with A-V fistula, an experimental model of high-output heart failure, display a markedly attenuated response to administration of synthetic atrial natriuretic factor compared to sham-operated control rats. This conclusion is based on the following findings: First, the diuretic and natriuretic effects of ANF were significantly lower in rats with A-V fistula compared to sham operated rats. In addition, the dose response curve of ANF-induced natriuresis was shifted to the right in rats with A-V fistula, suggesting a Values are means SE for six animals. Abbreviations are given in Table 2 .
P 0.05 compared to first period where no ANF was administered b P < 0.05 compared to previous dose of ANF to this group. However, during infusion of this dose there were no further changes in blood pressure. Indeed, with the exception of the fractional excretion of sodium, other parameters actually declined. The responses of both sham operated rats and rats with A-v fistula to increasing doses of ANF are compared in Figures 2  and 3 . The glomerular filtration rate (Fig. 2) and, the fractional excretion of sodium (Fig. 3) are plotted for each dose of ANF. In this series, the baseline values for the glomerular filtration rate and fractional excretion of sodium were significantly lower in rats with A-V fistula compared to sham operated controls. Furthermore, the increases in both parameters following ANF administration were significantly attenuated in rats with A-V fistula. Indeed, there was no significant increase in the glomerular filtration rate and the fractional excretion of sodium, even at the highest dose of ANF, was only 2%-a significantly lower value than in control rats. This apparent "shift to the right" of the dose response curve suggests either that rats with A-V fistula have diminished sensitivity to ANF or that perhaps the lower baseline systemic blood pressure altered the hemodynamic and, consequently, the natriuretic response to ANF. To further examine this issue, the next series was performed wherein renal perfusion pressure was lowered in normal rats to the level seen in rats with A-V fistula.
Response to ANF in normal rats during control of renal perJision pressure The results of this series of experiments are shown in Figure  4 . Renal perfusion pressure in normal rats was lowered from 134 mm Hg to 110 mm Hg, and maintained at that level throughout the experiment. Administration of ANF lead to significant increases in glomerular filtration rate (from 1.01 0.11 to 1.38 0.29 mI/mm, P < 0.05), urine flow (from 9 2 to 33 3 p11mm, P < 0.05) and fractional excretion of sodium (from 0.5 0.2 to 2.7 0.3%, P < 0.05). The results demonstrate that a significant natriuresis and diuresis can occur in an animal with moderately-reduced renal perfusion pressure. More importantly, these data indicate that the blunted natriuresis and diuresis that occurred in response to ANF in rats with A-V fistula is not a direct result of the lower renal perfusion pressure present in those animals.
The present study demonstrates that rats with A-V fistula, an experimental model of high-output heart failure, display a markedly attenuated response to administration of synthetic atrial natriuretic factor compared to sham-operated control rats. This conclusion is based on the following findings: First, the diuretic and natriuretic effects of ANF were significantly lower in rats with A-V fistula compared to sham operated rats. In addition, the dose response curve of ANF-induced natriuresis was shifted to the right in rats with A-V fistula, suggesting a The results of this study are consistent with previous reports regarding the effects of ANF on sodium excretion in other experimental models of heart failure. In both conscious [23] and anesthetized dogs with low-output heart failure [24] , the natriuretic response to synthetic atrial peptide was attenuated compared to normal dogs. However, in contrast to the present findings, ANF induced similar increases in the glomerular filtration rate and decreases in blood pressure in controls and in animals with heart failure. This discrepancy may highlight a fundamental difference between the two experimental models of heart failure. The model of chronic A-V fistula used in the present study represents a state of high atrial pressures and elevated plasma levels of ANF, similar to the clinical syndrome of congestive heart failure. It is possible that the genera'ized resistance to the effects of ANF, observed in this model, relates to the high circulating levels of endogenous atrial peptides (Fig.   1 ). The presence of chronically elevated levels of ANF may have lead to receptor "down-regulation" and, consequently, to decreased end-organ responsiveness. Indeed, "down-regulation" of binding sites has been recently reported by Schiffrin to occur in platelets of patients with congestive heart failure [30] . The high circulating levels of ANF may explain the finding of a lower baseline blood pressure in rats with A-V fistula and the minimal decrease in blood pressure following infusion of increasing doses of the peptide to these animals. On the other hand, it would not explain the lower baseline glomerular filtration rate and sodium excretion also present in these animals.
It is likely that additional mechanisms contribute to the blunted natriuretic response to ANF in heart failure. Freeman, Davis and Van suggested that the natriuretic response to ANF infusion is dependent on the pre-existing status of the renal tubules to reabsorb sodium [23] . In experimental models of heart failure, there are several factors that may promote avid sodium reabsorption and lead to the very low basal excretion of sodium. In particular, activation of the renin-angiotensin-aldosterone system and increases in renal sympathetic nerve activity are known to occur in heart failure [13, 14, 31] , and may enhance the renal retention of sodium and overcome the natriuretic effects of ANF. Indeed, we have found elevated plasma renin activity in rats with A-V fistula compared to controls (Table 1) . Clearly, the role of these systems in modulating the effects of ANF, particularly in states of sodium retention, needs to be carefully investigated. Of interest are the findings regarding the effect of ANF in normal rats during control of renal perfusion pressure. The purpose of that series was to determine whether the lower renal perfusion pressure (110 mm Hg), that was present in rats with A-V fistula, contributed to the attenuated natriuretic response to ANF infusion in that group. The data demonstrate that a significant natriuresis and diuresis occurred in normal rats when renal perfusion pressure was moderately reduced to 110 mm Hg. Based on that finding, it was concluded that the blunted natriuretic response to ANF in rats with A-V fistula cannot be due solely to the lower renal perfusion pressure. However, the fact that the magnitude of the natriuresis at a perfusion pressure of 110 mm Hg (FENa = 2.7 3%) was less than was observed in normal rats at renal perfusion pressures of 134 mm Hg (FENa = 5.5 0.8%) indicates that the level of renal perfusion pressure is an important factor in establishing the magnitude of the natriuretic response to ANF. Thus, these data provide further evidence for an important relationship between intrarenal pressures and ANF-induced natriuresis. The results of this study are consistent with previous reports regarding the effects of ANF on sodium excretion in other experimental models of heart failure. In both conscious [23] and anesthetized dogs with low-output heart failure [24] , the natriuretic response to synthetic atrial peptide was attenuated compared to normal dogs. However, in contrast to the present findings, ANF induced similar increases in the glomerular filtration rate and decreases in blood pressure in controls and in animals with heart failure. This discrepancy may highlight a fundamental difference between the two experimental models of heart failure. The model of chronic A-V fistula used in the present study represents a state of high atrial pressures and elevated plasma levels of ANF, similar to the clinical syndrome of congestive heart failure. It is possible that the generalized resistance to the effects of ANF, observed in this model, relates to the high circulating levels of endogenous atrial peptides (Fig.   1 ). The presence of chronically elevated levels of ANF may have lead to receptor "down-regulation" and, consequently, to decreased end-organ responsiveness. Indeed, "down-regulation" of binding sites has been recently reported by Schiffrin to occur in platelets of patients with congestive heart failure [30] . The high circulating levels of ANF may explain the finding of a lower baseline blood pressure in rats with A-V fistula and the minimal decrease in blood pressure following infusion of increasing doses of the peptide to these animals. On the other hand, it would not explain the lower baseline glomerular filtration rate and sodium excretion also present in these animals.
It is likely that additional mechanisms contribute to the blunted natriuretic response to ANF in heart failure. Freeman, Davis and Van suggested that the natriuretic response to ANF infusion is dependent on the pre-existing status of the renal tubules to reabsorb sodium [23] . In experimental models of heart failure, there are several factors that may promote avid sodium reabsorption and lead to the very low basal excretion of sodium. In particular, activation of the renin-angiotensin-aldosterone system and increases in renal sympathetic nerve activity are known to occur in heart failure [13, 14, 31] , and may enhance the renal retention of sodium and overcome the natriuretic effects of ANF. Indeed, we have found elevated plasma renin activity in rats with A-V fistula compared to controls (Table I) . Clearly, the role of these systems in modulating the effects of ANF, particularly in states of sodium retention, needs to be carefully investigated.
Of interest are the findings regarding the effect of ANF in normal rats during control of renal perfusion pressure. The purpose of that series was to determine whether the lower renal perfusion pressure (110 mm Hg), that was present in rats with A-V fistula, contributed to the attenuated natriuretic response to ANF infusion in that group. The data demonstrate that a significant natriuresis and diuresis occurred in normal rats when renal perfusion pressure was moderately reduced to 110 mm Hg. Based on that finding, it was concluded that the blunted natriuretic response to ANF in rats with A-V fistula cannot be due solely to the lower renal perfusion pressure. However, the fact that the magnitude of the natriuresis at a perfusion pressure of 110 mm Hg (FENa = 2.7 3%) was less than was observed in normal rats at renal perfusion pressures of 134 mm Hg (FENa = 5.5 0.8%) indicates that the level of renal perfusion pressure is an important factor in establishing the magnitude of the natriuretic response to ANF. Thus, these data provide further evidence for an important relationship between intrarenal pressures and ANF-induced natriuresis.
